| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |